394
Participants
Start Date
February 28, 2006
Primary Completion Date
November 30, 2006
Study Completion Date
November 30, 2006
Aluminum hydroxide
Provided in vials that contain 0.8 mL volume per vial.
Inactivated Influenza A/H5N1 Vaccine (Chiron)
Monovalent subvirion H5N1 vaccine (HA of A/Vietnam/1203/04) provided in unit-dose vials containing 60 mcg/mL A/H5N1 HA as determined by single radial immunodiffusion. It may be formulated with MF59 or aluminum hydroxide. Dosages: 7.5 mcg, 15 mcg, 30 mcg, or 45 mcg.
MF-59
Proprietary experimental adjuvant. Provided in vials that contain 0.7 mL volume per vial.
Placebo
Saline placebo.
Vanderbilt University, Nashville
Saint Louis University, St Louis
Stanford University, Stanford
Cincinnati Children's Hospital Medical Center, Cincinnati
National Institute of Allergy and Infectious Diseases (NIAID)
NIH